La Ventana Treatment Programs Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • La Ventana Treatment Programs's estimated annual revenue is currently $10.9M per year.(i)
  • La Ventana Treatment Programs's estimated revenue per employee is $140,000

Employee Data

  • La Ventana Treatment Programs has 78 Employees.(i)
  • La Ventana Treatment Programs grew their employee count by -2% last year.

La Ventana Treatment Programs's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Strategy OfficerReveal Email/Phone
3
Executive Clinical DirectorReveal Email/Phone
4
Residential Detox ManagerReveal Email/Phone
5
Admissions AdministratorReveal Email/Phone
6
President & Chairman the BoardReveal Email/Phone
7
Marriage And Family TherapistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$212.8M10635%$65MN/A
#2
$35.6M2316%N/AN/A
#3
$45M299-4%$102.6MN/A
#4
$3.2M30-25%$21.3MN/A
#5
$34M2260%$42.9MN/A
#6
$3.6M34-28%$35MN/A
#7
$0.8M10N/AN/AN/A
#8
$12.6M90-9%N/AN/A
#9
$17.4M1240%$96.4MN/A
#10
$5.2M49-25%$75.6MN/A
Add Company

What Is La Ventana Treatment Programs?

La Ventana Treatment Programs of California offers a holistic, state of the art approach to treating those struggling with mental health, substance use and co-occurring issues. Our individualized approach offers a continuum of care to accommodate high acuity illness by offering: GENDER-SPECIFIC TRAUMA RECOVERY RESIDENTIAL TREATMENT, NON-BINARY MENTAL HEALTH RESIDENTIAL TREATMENT, SUB-ACUTE DETOX licensed for IMS, PHP, IOP, and structured client housing. La Ventana is accredited by The Joint Commission, licensed by DHCS, and accepts most major insurances. Call 800-560-8518 for a confidential clinical assessment.

keywords:N/A

N/A

Total Funding

78

Number of Employees

$10.9M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

La Ventana Treatment Programs News

2022-04-06 - Metastatic Cancer Drug Market Size Worth $68.34Bn, Globally ...

Metastatic Cancer Treatment Market Forecast to 2028 - COVID-19 Impact and Global ... Ambulatory Surgical Centers and Others) and Geography.

2022-04-06 - Aberrant R-loop-induced replication stress in MED12-mutant ...

Accordingly, alternative treatment options with superior tumor ... in gene expression programs that control diverse physiological processes,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M7913%N/A
#2
$11.6M803%N/A
#3
$14.8M8212%N/A
#4
$21.8M87-5%N/A
#5
$19.4M881%N/A